BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22216342)

  • 1. The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients.
    Liu X; Cai H; Huang H; Long Z; Shi Y; Wang Y
    PLoS One; 2011; 6(12):e29670. PubMed ID: 22216342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
    Liu X; Yu H; Cai H; Wang Y
    J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression.
    Lima VP; de Lima MA; André AR; Ferreira MV; Barros MA; Rabenhorst SH
    World J Gastroenterol; 2008 Feb; 14(6):884-91. PubMed ID: 18240345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
    Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
    Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of apoptosis-related markers TP53, BCL-2, BAX and c-MYC in female genital tract sarcomas.
    Liu FS; Jan YJ; Lai CR; Twu NF; Lu CH; Hung MJ; Hsieh YT; Chiou LC
    J Chin Med Assoc; 2008 Dec; 71(12):628-34. PubMed ID: 19114327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors?
    Zafirellis K; Karameris A; Milingos N; Androulakis G
    Anticancer Res; 2005; 25(5):3629-36. PubMed ID: 16101192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical expression of bcl-2, bcl-xL, bax, p53 proteins in gastric adenoma and adenocarcinoma].
    Lee DS; Kang SB; Baek JT; Nam SW; Lee KM; Ahn BM; Lee EH; Han SW; Chung IS
    Korean J Gastroenterol; 2005 Jun; 45(6):394-400. PubMed ID: 15973073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression of bax, bcl-2, and p53 in patients with non-Hodgkin's gastric lymphoma: prognostic significance.
    Charalambous GK; Gomatos IP; Konstadoulakis MM; Messaris EG; Manouras AJ; Apostolou AE; Leandros EA; Karayannis MK; Androulakis GA
    World J Surg; 2000 May; 24(5):608-14. PubMed ID: 10787085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis dysregulation in human gastric carcinomas: relationship to anti- and pro-apoptotic protein expression.
    Nasif WA; El-Emshaty HM; Lotfy M; Zalata K; El-Hak NG
    Asian Pac J Cancer Prev; 2007; 8(1):45-50. PubMed ID: 17477770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signaling pathways.
    Wang Y; Xiao H; Wang C; Wu H; He H; Yao C; Cui J; Li W
    J Cell Biochem; 2020 Mar; 121(3):2330-2342. PubMed ID: 31692032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Bcl-2 and p53 expression in gastric cancer.
    Lee HK; Lee HS; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Int J Colorectal Dis; 2003 Nov; 18(6):518-25. PubMed ID: 12811476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF4 expression and apoptosis-related markers in gastric cancer.
    Krstic M; Stojnev S; Jovanovic L; Marjanovic G
    J BUON; 2013; 18(3):695-702. PubMed ID: 24065485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins.
    Ishii H; Gobé G; Kawakubo Y; Sato Y; Ebihara Y
    Histopathology; 2001 Feb; 38(2):111-9. PubMed ID: 11207824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and related proteins in epithelial ovarian cancer.
    Sengupta PS; McGown AT; Bajaj V; Blackhall F; Swindell R; Bromley M; Shanks JH; Ward T; Buckley CH; Reynolds K; Slade RJ; Jayson GC
    Eur J Cancer; 2000 Dec; 36(18):2317-28. PubMed ID: 11094305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma.
    Inada T; Kikuyama S; Ichikawa A; Igarashi S; Ogata Y
    Anticancer Res; 1998; 18(3B):2003-10. PubMed ID: 9677457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
    Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
    Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of biological apoptosis factors in gastric cancer.
    Sezer C; Yildirim M; Yildiz M; Sezgin A; Donem Dilli U; Goktas S; Bulbuller N
    J BUON; 2013; 18(1):138-46. PubMed ID: 23613399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.